To mark Breast Cancer Awareness Month, we are joined in this moving and potentially life-saving mdtalk by Sheila Mikhail, Executive Director of Columbus Children's Foundation and Co-Founder and Advisor at Ask Bio.

We recently hosted a very special live podcast recording. In place of our usual mdtalk, we facilitated a live round table of experts to discuss the impact of decentralisation in clinical trials.

In this jam-packed, fascinating discussion, representatives from the patient community, sponsors, sites, and clinical operations all sat around the virtual table for the very first time to debate our common challenges:

• The barriers to participation in traditional clinical trials

Host LaQuinta Jernigan, Chief Operating Officer at mdgroup, was joined by:

• Jameka Hill - Senior Director of Clinical Trial Health Equity at Moderna

For this motivating episode of mdtalk, host LaQuinta Jernigan, Chief Operating Officer at mdgroup, was joined by Dr Eneida Nemecek. 

Eneida is Medical Director of Clinical Research and Pediatric and Medical Oncology Doctor. at Oregon Health & Science University. Eneida is also dedicated to promoting diversity in healthcare and volunteers in a range of roles for incredible charities. 

LaQuinta and Eneida discussed Eneida’s experience as a medical doctor and professor; how these experiences have influenced her to dedicate herself to making healthcare equitable; and the vital role clinical research plays in creating health equity.

For this episode of mdtalk, host and COO of mdgroup, LaQuinta Jernigan, is joined by Stephanie Katz, Director of mdgroup’s sister company, seacolehealth.  

seacolehealth is a talent agency for healthcare and research professionals seeking flexible and rewarding opportunities to work in patient healthcare and clinical studies worldwide. Their nurses and healthcare professionals deliver remarkable patient experiences for traditional, decentralised, and hybrid clinical trials.  

Stephanie is a registered nurse who joined the seacolehealth team in 2021. Before this, she worked at the renowned Johns Hopkins Hospital in Baltimore, Maryland, USA, where she started as a nurse clinician before becoming a research nurse manager.

Episode 12 is a very special edition of mdtalk. Host LaQuinta Jernigan, Chief Operating Officer at mdgroup, is joined by Jennifer Kinnebrew, Shaniece Goodlow, and Maggie Settlemire.

These incredible women have kindly agreed to join us to discuss their experiences of having children with rare diseases, and how we can advocate better care for everyone.

2022 was a big year for clinical trials.  From supply chain disruptions and staffing shortages to slowing the MedTech boom of 2021, we have weathered some significant challenges.

In Episode 11 of mdtalk, host LaQuinta Jernigan, Chief Operating Officer at mdgroup, is joined by Tom Brazier, our Director of Decentralised Clinical Solutions and mdgroup’s Chief Executive Officer, Tarquin Scadding-Hunt. 

They reflect on the past year and explore their predictions and hopes for 2023.

In Episode 10 of mdtalk, host LaQuinta Jernigan (mdgroup’s Chief Operating Officer) is joined by Caroline Jackson, mdgroup’s Executive Vice President of Patient Services, to discuss the pros and cons of hybrid clinical studies and explore how we can work to make clinical trials more accessible, cost-efficient and patient-focused.

Digital transformation in healthcare is a hot topic for clinical trial organisers and sponsors – and a complex one too.

In this episode, mdgroup’s Chief Operating Officer LaQuinta Jernigan is joined by Adam Spinks and Lyndon Johnson from 8fold Governance. Together, they delve into the challenges posed by the rapid advancement of medical technology and why compliance, good governance and patient-centricity are vitally important wherever technology is adopted.

Collectively, 8fold Governance has almost 100 years of combined experience in the UK health sector and provides end-to-end services for health technology companies including information governance, compliance, clinical safety, software development and more.

This episode focuses on disparity in clinical trial participation between patient populations, industry innovations to improve health equity, the accelerated movement towards decentralised trials – and what all this means for patient accessibility, diversity and engagement. 

Our host LaQuinta Jernigan, Chief Operating Officer at mdgroup, speaks with Adam Samson, Head of Clinical Delivery Operations, RWE Clinical Trials at Walgreens, to understand the importance of trial design for health equity.

Adam is an expert at conducting clinical trials across multiple therapeutic areas as a coordinator, monitor, project manager, and executive within academia, sites, CROs, pharma, tech, and retail pharmacy. He currently serves as Head of Clinical Delivery Operations at Walgreens where his primary role is to operationalise existing locations to conduct clinical trials.

Adam also serves as adjunct faculty at The George Washington University in the Master's in Clinical Research Administration program, as well as serving as a core member in the Decentralized Trials & Research Alliance (DTRA) working group to map the participant journey in decentralised clinical trials.

This episode is focused on women's health, and how disparities in access to care due to race, culture and socio-economic status can and must be addressed. As well as discussing the causes and solutions to this issue, the hosts will also consider how healthcare accessibility relates to clinical research today.

LaQuinta Jernigan, Chief Operating Officer at mdgroup, and co-host Sarrah Val, our Regional Sales Director for the Americas, speak with Christine Roy-McMahon MD, attending OB-GYN at Elmhurst Hospital HHC.

Dr Roy-McMahon has a Major in neurobiology from the Florida International University Herbert Wertheim College of Medicine with a sub-specialism in benign gynaecological surgery, focusing on minimally invasive techniques. She primarily takes care of uninsured, underinsured and underrepresented minorities and is passionate about working on equity of care and access for those groups.